China Loratadine Market 2018-2022: Market Competition is Fierce but the Brand-Name Drug Still has Great Advantages
DUBLIN, Jan 8, 2019 /PRNewswire/ --
The "Investigation Report on China's Loratadine Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The incidences of common skin redness, itching and rashes and respiratory allergies are rising as China's economy develops, the living environment and dietary structure change, and environmental pollution intensifies, which drives the growth of the antihistamine market.
As a second-generation antihistamine, Loratadine is a common H1 receptor antagonist used to relieve the symptoms of allergic rhinitis, eye itching and burning sensation, and the symptoms and signs of chronic urticaria, pruritic skin diseases and other allergic skin diseases. It can quickly relieve nose and eye allergies. Moreover, Loratadine has a low affinity for the H1 receptor of the central nervous system, and thus has hardly any side effect on the nervous system.
Developed by Schering-Plough which has been acquired by Bayer, Loratadine (trade name: Clarityne) was first launched in Belgium in 1988 and then sold in several European countries. In Apr. 1993, it was approved by the FDA to be marketed in the U.S. In Sept. 2002, it was launched in Japan. In November of the same year, the FDA approved Clarityne as a non-prescription drug.
According to the researcher, in Jun. 1993, imported Loratadine tablets were approved to be sold in China under the trade name Clarityne. In 2005, the CFDA approved Clarityne as a non-prescription drug for its excellent effect and long-tested safety. Many Chinese companies have launched generic Loratadine products in the dosage forms of oral tablets, capsules, granules, syrup and compound preparation.
The market competition is fierce but the brand-name drug still has great advantages. In 2017, Shanghai Schering-Plough Pharmaceutical Co., Ltd. and Schering-Plough occupied about 65% market share by sales value. But the market share of the brand-name drug showed a downward trend.
Loratadine has secured a place on the market by advantage of long-lasting and quick-acting effect and rare adverse reactions. However, with the increasing number of Loratadine manufacturers and intensifying competition on the market, the average price of Loratadine is declining.
It is expected that as the incidences of allergic diseases continue to increase, China's Loratadine market will still has some growth potential in the next few years.
Key Topics Covered:
1 Relevant Concepts of Loratadine
1.1 Indications for Loratadine
1.2 Development of Loratadine in China
1.3 Governmental Approval of Loratadine in China
2 Sales of Loratadine in China, 2013-2017
2.1 Sales Value of Loratadine in China
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Loratadine
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Loratadine by Dosage Form in China, 2013-2017
2.3.1 Sales of Loratadine Tablets in China
2.3.2 Sales of Loratadine Capsules in China
2.3.3 Sales of Loratadine Granules in China
2.3.4 Sales of Loratadine Syrups in China
3 Analysis of Major Loratadine Manufacturers in China, 2013-2017
3.1 Analysis on Market Shares of Major Loratadine Manufacturers in China
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Shanghai Schering-Plough Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Shanghai Schering-Plough Pharmaceutical Co., Ltd.'s Loratadine in China
3.3 Schering-Plough
3.3.1 Enterprise Profile
3.3.2 Sales of Schering Plough's Loratadine in China
3.4 Beijing SL Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Beijing SL Pharmaceutical Co., Ltd.'s Loratadine in China
3.5 Venturepharm Pharmaceutical (Hainan) Co., Ltd.
3.6 Jiangsu Hanchen Pharmaceutical Co., Ltd.
4 Prices of Loratadine in China, 2017-2018
4.1 Shanghai Schering-Plough Pharmaceutical Co., Ltd. (Clarityne)
4.2 Schering-Plough (Clarityne)
4.3 Beijing SL Pharmaceutical Co., Ltd. (Leining)
4.4 Venturepharm Pharmaceutical Co., Ltd. (Baiweile)
4.5 Jiangsu Hanchen Pharmaceutical Co., Ltd. (Yibaizhi)
5 Prospect of China's Loratadine Market, 2018-2022
5.1 Major Factors Influencing Development of China's Loratadine Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
For more information about this report visit https://www.researchandmarkets.com/research/7bptnk/china_loratadine?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article